Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announces that it has successfully completed the divestiture of its Advanced Rehabilitation business to Accelmed Partners (“Accelmed”), a private equity firm focused on acquiring and growing commercial-stage HealthTech companies. The transaction, announced on October 1, 2024, enables Bioventus to continue improving its focus and execution within the Company’s core businesses, while also delivering approximately $20 million of net closing proceeds to enhance liquidity.
Read the full article: Bioventus Completes Divestiture of Its Advanced Rehabilitation Business to Accelmed Partners //
Source: https://www.globenewswire.com/news-release/2025/01/02/3003496/0/en/Bioventus-Completes-Divestiture-of-its-Advanced-Rehabilitation-Business-to-Accelmed-Partners.html